Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 04 2022
Historique:
received: 07 12 2021
accepted: 23 03 2022
entrez: 9 4 2022
pubmed: 10 4 2022
medline: 13 4 2022
Statut: epublish

Résumé

Global genomic surveillance of SARS-CoV-2 has identified variants associated with increased transmissibility, neutralization resistance and disease severity. Here we report the emergence of the PANGO lineage C.1.2, detected at low prevalence in South Africa and eleven other countries. The initial C.1.2 detection is associated with a high substitution rate, and includes changes within the spike protein that have been associated with increased transmissibility or reduced neutralization sensitivity in SARS-CoV-2 variants of concern or variants of interest. Like Beta and Delta, C.1.2 shows significantly reduced neutralization sensitivity to plasma from vaccinees and individuals infected with the ancestral D614G virus. In contrast, convalescent donors infected with either Beta or Delta show high plasma neutralization against C.1.2. These functional data suggest that vaccine efficacy against C.1.2 will be equivalent to Beta and Delta, and that prior infection with either Beta or Delta will likely offer protection against C.1.2.

Identifiants

pubmed: 35396511
doi: 10.1038/s41467-022-29579-9
pii: 10.1038/s41467-022-29579-9
pmc: PMC8993834
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1976

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI138546
Pays : United States
Organisme : ACL HHS
ID : U01IP001048
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : U01 AI151698
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP001048
Pays : United States
Organisme : Wellcome Trust
ID : 221003/Z/20/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 222574/Z/21/Z
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Lancet Microbe. 2020 Oct;1(6):e229-e230
pubmed: 32838349
Nature. 2021 Mar;591(7849):293-299
pubmed: 33494095
N Engl J Med. 2021 Jun 3;384(22):2161-2163
pubmed: 33826816
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Cell. 2020 Dec 23;183(7):1901-1912.e9
pubmed: 33248470
Virus Evol. 2020 Apr 12;7(1):veaa087
pubmed: 33936774
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Science. 2021 Oct 22;374(6566):423-431
pubmed: 34672751
Bioinformatics. 2016 Oct 15;32(20):3204-3206
pubmed: 27334476
Nat Commun. 2021 Jul 7;12(1):4196
pubmed: 34234131
iScience. 2022 Jan 21;25(1):103589
pubmed: 34909610
N Engl J Med. 2021 May 20;384(20):1885-1898
pubmed: 33725432
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Bioinformatics. 2020 Jun 1;36(11):3552-3555
pubmed: 32108862
Mol Biol Evol. 2022 Feb 3;39(2):
pubmed: 35038741
Cell Host Microbe. 2021 Jul 14;29(7):1093-1110
pubmed: 34242582
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
Nat Med. 2021 Apr;27(4):622-625
pubmed: 33654292
Bioinformatics. 2014 Nov 15;30(22):3276-8
pubmed: 25095880
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
J Infect. 2021 Apr;82(4):e27-e28
pubmed: 33383088
Nat Commun. 2022 Jan 24;13(1):460
pubmed: 35075154
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Bioinformatics. 2019 Mar 1;35(5):871-873
pubmed: 30124794
Philos Trans R Soc Lond B Biol Sci. 1994 Jun 29;344(1310):403-10
pubmed: 7800710
Cell. 2021 Apr 15;184(8):2201-2211.e7
pubmed: 33743891
N Engl J Med. 2021 Aug 5;385(6):562-566
pubmed: 34347959
Nat Med. 2021 Mar;27(3):440-446
pubmed: 33531709
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300

Auteurs

Cathrine Scheepers (C)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, 2132, Johannesburg, South Africa.

Josie Everatt (J)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.

Daniel G Amoako (DG)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.

Houriiyah Tegally (H)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.
Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, 7600, Stellenbosch, South Africa.

Constantinos Kurt Wibmer (CK)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.

Anele Mnguni (A)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.

Arshad Ismail (A)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.

Boitshoko Mahlangu (B)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.

Bronwen E Lambson (BE)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, 2132, Johannesburg, South Africa.

Darren P Martin (DP)

Institute of Infectious Disease and Molecular Medicine, University of Cape Town, 7925, Cape Town, South Africa.

Eduan Wilkinson (E)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.
Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, 7600, Stellenbosch, South Africa.

James Emmanuel San (JE)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.
Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, 7600, Stellenbosch, South Africa.

Jennifer Giandhari (J)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.

Nelia Manamela (N)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, 2132, Johannesburg, South Africa.

Noxolo Ntuli (N)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.

Prudence Kgagudi (P)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, 2132, Johannesburg, South Africa.

Sandile Cele (S)

Africa Health Research Institute, 4001, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, 4041, Durban, South Africa.

Simone I Richardson (SI)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, 2132, Johannesburg, South Africa.

Sureshnee Pillay (S)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.

Thabo Mohale (T)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.

Upasana Ramphal (U)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.

Yeshnee Naidoo (Y)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.
Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, 7600, Stellenbosch, South Africa.

Zamantungwa T Khumalo (ZT)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, 0110, Onderstepoort, South Africa.

Gaurav Kwatra (G)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, 2000, Johannesburg, South Africa.
Department of Clinical Microbiology, Christian Medical College, Vellore, 632004, India.

Glenda Gray (G)

South African Medical Research Council, 7505, Cape Town, South Africa.

Linda-Gail Bekker (LG)

Desmond Tutu HIV Centre, 7925, Cape Town, South Africa.

Shabir A Madhi (SA)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, 2000, Johannesburg, South Africa.

Vicky Baillie (V)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, 2000, Johannesburg, South Africa.

Wesley C Van Voorhis (WC)

Center for Emerging and Re-emerging Infectious Diseases (CERID), University of Washington, Washington, 98195, USA.

Florette K Treurnicht (FK)

National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
Faculty of Health Sciences, University of the Witwatersrand, 2193, Johannesburg, South Africa.

Marietjie Venter (M)

Zoonotic Arbo and Respiratory Virus Research Programme, Department of Medical Virology, Faculty of Health, University of Pretoria, 0031, Gezina, South Africa.

Koleka Mlisana (K)

School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, 4041, Durban, South Africa.
National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
Clinical Microbiology and Infectious Diseases Unit, Faulty of Health Sciences, University of Witwatersrand, 2132, Johannesburg, South Africa.

Nicole Wolter (N)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
Faculty of Health Sciences, University of the Witwatersrand, 2193, Johannesburg, South Africa.

Alex Sigal (A)

Africa Health Research Institute, 4001, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, 4041, Durban, South Africa.
Max Planck Institute for Infection Biology, 10117, Berlin, Germany.

Carolyn Williamson (C)

Institute of Infectious Disease and Molecular Medicine, University of Cape Town, 7925, Cape Town, South Africa.
National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), 7925, Cape Town, South Africa.

Nei-Yuan Hsiao (NY)

Institute of Infectious Disease and Molecular Medicine, University of Cape Town, 7925, Cape Town, South Africa.
National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), 7925, Cape Town, South Africa.

Nokukhanya Msomi (N)

National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
Discipline of Virology, University of KwaZulu-Natal, 4041, Durban, South Africa.

Tongai Maponga (T)

Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, 7602, Cape Town, South Africa.

Wolfgang Preiser (W)

National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, 7602, Cape Town, South Africa.

Zinhle Makatini (Z)

National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
Faculty of Health Sciences, University of the Witwatersrand, 2193, Johannesburg, South Africa.

Richard Lessells (R)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.

Penny L Moore (PL)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, 2132, Johannesburg, South Africa.
Institute of Infectious Disease and Molecular Medicine, University of Cape Town, 7925, Cape Town, South Africa.
Centre for the AIDS Programme of Research in South Africa (CAPRISA), 4013, KwaZulu-Natal, South Africa.

Tulio de Oliveira (T)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 4001, Durban, South Africa.
Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, 7600, Stellenbosch, South Africa.

Anne von Gottberg (A)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa.
Faculty of Health Sciences, University of the Witwatersrand, 2193, Johannesburg, South Africa.
Faculty of Health Sciences, University of Cape Town, 7935, Cape Town, South Africa.

Jinal N Bhiman (JN)

National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), 2131, Johannesburg, South Africa. jinalb@nicd.ac.za.
Faculty of Health Sciences, University of the Witwatersrand, 2193, Johannesburg, South Africa. jinalb@nicd.ac.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH